NEUROFIRST Trademark

Trademark Overview

On Wednesday, September 27, 2023, a trademark application was filed for NEUROFIRST with the United States Patent and Trademark Office. The USPTO has given the NEUROFIRST trademark a serial number of 98199861. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Friday, October 31, 2025. This trademark is owned by Cx Precision Medicine, Inc.. The NEUROFIRST trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical diagnostic and testing services; medical diagnostic and testing services in the field of neurodegenerative diseases
neurofirst

General Information

Serial Number98199861
Word MarkNEUROFIRST
Filing DateWednesday, September 27, 2023
Status731 - SECOND EXTENSION - GRANTED
Status DateFriday, October 31, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 17, 2024

Trademark Statements

Goods and ServicesMedical diagnostic and testing services; medical diagnostic and testing services in the field of neurodegenerative diseases
Pseudo MarkNEURO FIRST; NEURO1ST; NEURO 1ST

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 11, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCx Precision Medicine, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFort Worth, TX 76107
Party NameCx Precision Medicine, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFort Worth, TX 76107

Trademark Events

Event DateEvent Description
Saturday, September 30, 2023NEW APPLICATION ENTERED
Wednesday, October 11, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 20, 2024ASSIGNED TO EXAMINER
Monday, June 10, 2024NON-FINAL ACTION WRITTEN
Monday, June 10, 2024NON-FINAL ACTION E-MAILED
Monday, June 10, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 2, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 2, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 2, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 28, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 17, 2024PUBLISHED FOR OPPOSITION
Tuesday, September 17, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 12, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 6, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, May 6, 2025SOU EXTENSION 1 FILED
Wednesday, May 7, 2025SOU EXTENSION 1 GRANTED
Wednesday, May 7, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 31, 2025SOU TEAS EXTENSION RECEIVED
Friday, October 31, 2025SOU EXTENSION 2 FILED
Friday, October 31, 2025SOU EXTENSION 2 GRANTED
Saturday, November 1, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

neurofirst medical testing services diagnostic diseases field neurodegenerative